Sunitinib is an agent approved for kidney cancer patients which has been shown to extend life by 4–6 months at an annual cost of $54,000. Discuss as a healthcare decision-maker (i.e., payer) when you would approve prescribing this drug on economic as di Ace myhomework myhomework writers acemywork

has been scientifically proven to be able to extend one’s life by four to six months, costing annually $54,000. Obviously, the cost of such a medication sometimes overshadows the fact that many people cannot afford such an expensive medication—as $54K